TWi Pharmaceuticals Inc (4180)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:TWi Pharmaceuticals Inc (4180) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013456
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:台湾
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
TWi Pharmaceuticals Inc (TWi), formerly Anchen Pharmaceuticals (Taiwan) Inc is a manufacturer of high barrier generics drugs. The company’s products include donepezil hydrochloride tablets, hydroquinone cream, hydroquinone time release cream, megestrol acetate oral suspension and nifedipine extended-release tablets. Its drugs consists of oral controlled release dosage form, non-oral parental and transdermal products, novel drug delivery systems, and polymeric oral delivery systems. The company develops oral high barrier generic prescription products for muscle relaxants, hypertension, vasospatic agina, anorexia, cachexia, alzheimar’s diseases, and others. TWi is headquartered in Taipei, Taiwan.

TWi Pharmaceuticals Inc (4180) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
TWi Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
TWi Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
TWi Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
TWi Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
TWi Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
TWi Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 10
Licensing Agreements 10
Castle Creek Pharma Enters into Licensing Agreement with TWi Biotechnology 10
Industrial Technology Research Institute Enters Into Licensing Agreement With TWI Biotech For ITRI-260 11
Equity Offering 12
TWi Biotechnology to Raise USD17.5 Million in IPO 12
TWi Pharma Raises USD87 Million in Public Offering of Global Depository Receipts 13
TWi Pharma Completes IPO 14
TWi Pharma Announces Private Placement Of Shares For US$11 Million 15
Acquisition 16
TWi Pharmaceutical Cayman to Sell its Stake in Hainan-Based Pharmaceuticals Company for USD28.6 Million 16
TWi Pharma to Acquire 50% Stake in Hainan Visum Pharma 17
TWi Pharma Acquires U-Liang Pharma 18
TWi Pharmaceuticals Inc – Key Competitors 19
TWi Pharmaceuticals Inc – Key Employees 20
TWi Pharmaceuticals Inc – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
TWi Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
TWi Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
TWi Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
TWi Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
TWi Pharmaceuticals Inc, Deals By Therapy Area, 2011 to YTD 2017 8
TWi Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Castle Creek Pharma Enters into Licensing Agreement with TWi Biotechnology 10
Industrial Technology Research Institute Enters Into Licensing Agreement With TWI Biotech For ITRI-260 11
TWi Biotechnology to Raise USD17.5 Million in IPO 12
TWi Pharma Raises USD87 Million in Public Offering of Global Depository Receipts 13
TWi Pharma Completes IPO 14
TWi Pharma Announces Private Placement Of Shares For US$11 Million 15
TWi Pharmaceutical Cayman to Sell its Stake in Hainan-Based Pharmaceuticals Company for USD28.6 Million 16
TWi Pharma to Acquire 50% Stake in Hainan Visum Pharma 17
TWi Pharma Acquires U-Liang Pharma 18
TWi Pharmaceuticals Inc, Key Competitors 19
TWi Pharmaceuticals Inc, Key Employees 20
TWi Pharmaceuticals Inc, Other Locations 21
TWi Pharmaceuticals Inc, Subsidiaries 21

★海外企業調査レポート[TWi Pharmaceuticals Inc (4180)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • RuralMetro Corp:企業の戦略的SWOT分析
    RuralMetro Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Lumberg Connect GmbH:企業の戦略的SWOT分析
    Lumberg Connect GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Safran Nacelles Ltd :企業の戦略・SWOT・財務情報
    Safran Nacelles Ltd - Strategy, SWOT and Corporate Finance Report Summary Safran Nacelles Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • China XD Plastics Co Ltd (CXDC):企業の財務・戦略的SWOT分析
    China XD Plastics Co Ltd (CXDC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Trinity Health:企業の戦略的SWOT分析
    Trinity Health - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Arcbest Corp.:企業の戦略・SWOT・財務分析
    Arcbest Corp. - Strategy, SWOT and Corporate Finance Report Summary Arcbest Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Allegheny Technologies Incorporated:企業の戦略・SWOT・財務情報
    Allegheny Technologies Incorporated - Strategy, SWOT and Corporate Finance Report Summary Allegheny Technologies Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Akcansa Cimento Sanayi ve Ticaret AS:企業の戦略・SWOT・財務情報
    Akcansa Cimento Sanayi ve Ticaret AS - Strategy, SWOT and Corporate Finance Report Summary Akcansa Cimento Sanayi ve Ticaret AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • GlobalData plc (PRO):企業の財務・戦略的SWOT分析
    Summary GlobalData Plc (GD), formerly Progressive Digital Media Group Plc, is a provider of data insights, analytics and information services. The company’s solutions encompass market and competitive analysis, strategic planning, mergers and acquisitions, financial decisions, legal and accounting, m …
  • Akers Biosciences Inc (AKER):医療機器:M&Aディール及び事業提携情報
    Summary Akers Biosciences Inc (ABI) is a medical device company that develops, manufactures and supplies point-of-care screening and testing products. The company provides clinical diagnostics, safety diagnostics, and wellness products. Its products include BreathScan alcohol detectors, CHUBE, METRO …
  • Biosearch Technologies Inc:医療機器:M&Aディール及び事業提携情報
    Summary Biosearch Technologies Inc (Biosearch), a subsidiary of LGC Ltd is a biotechnology company that designs and manufactures regents. The company develops, and manufactures custom oligonucleotide-based tools. Its products include valupanel reagents, fluorogenic probes and primers, stellaries RNA …
  • SOGLASIE Insurance Company Ltd.:企業の戦略・SWOT・財務情報
    SOGLASIE Insurance Company Ltd. - Strategy, SWOT and Corporate Finance Report Summary SOGLASIE Insurance Company Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Huaneng Power International Inc (600011):電力:M&Aディール及び事業提携情報
    Summary Huaneng Power International, Inc. (HPI) a subsidiary of Huaneng International Power Development Corporation is an independent power producer. The company together with its subsidiaries develops, constructs, operates and manages large thermal and hydro power plants in China. It owns a wholly- …
  • FANUC CORPORATION:企業の戦略・SWOT・財務分析
    FANUC CORPORATION - Strategy, SWOT and Corporate Finance Report Summary FANUC CORPORATION - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Sun Hydraulics Corporation:企業の戦略・SWOT・財務情報
    Sun Hydraulics Corporation - Strategy, SWOT and Corporate Finance Report Summary Sun Hydraulics Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • MVV Energie AG (MVV1):企業の財務・戦略的SWOT分析
    MVV Energie AG (MVV1) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • BP Plc (BP.):電力:M&Aディール及び事業提携情報
    Summary BP Plc (BP) is an integrated oil and gas company. Its upstream activities include exploration, development and production of oil and natural gas, field development and production; and midstream operations include transportation, and marketing and trading of natural gas, including liquefied n …
  • TelaDoc Inc (TDOC):医療機器:M&Aディール及び事業提携情報
    Summary TelaDoc Inc (Teladoc) is a provider of telehealth services. The company offers short term prescription for amoxicillin, azithromycin, bactrim DS, augmentin, cipro, tessalon perles, flonase nasal spray, pyridium, prednisone and diflucan. It provides telehealth services for cold and flu sympto …
  • Molecular Partners AG (MOLN):企業の財務・戦略的SWOT分析
    Summary Molecular Partners AG (Molecular Partners) is a clinical stage bio pharmaceutical company that develops biological drugs. The company offers advanced small protein therapies such as abicipar, a designed ankyrin repeat protein based anti-angiogenic drug developed for diabetic macular edema an …
  • Maxeda B.V.:企業の戦略・SWOT・財務情報
    Maxeda B.V. - Strategy, SWOT and Corporate Finance Report Summary Maxeda B.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆